Clinical trial of transdermal testosterone and oral levonorgestrel for male contraception

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 4, 1999, Pages 1244-1249

  Büchter, Dorothee ^a   Von Eckardstein, Sigrid ^a   Von Eckardstein, Arnold ^a   Kamischke, Axel ^a   Simoni, Manuela ^a   Behre, Hermann M ^a   Nieschlag, Eberhard ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; LEVONORGESTREL; LUTEINIZING HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; ARTICLE; AZOOSPERMIA; CLINICAL TRIAL; CONTRACEPTION; HORMONE INHIBITION; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SELF MEDICATION; SPERMATOZOON DENSITY;

EID: 0033323816     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.84.4.1244     Document Type: Article

References (24)

1. Testosterone in male contraception
2. Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: A promising male contraceptive approach
3. Clinical trial with levonorgestrel and testosterone oenanthate for male fertility control
4. Potential of testosterone buciclate for male contraception: Endocrine differences between responders and nonresponders
5. Depot-gonadotropin releasing hormone agonist blunts the androgen-induced suppression of spermatognesis in a clinical trial of male contraception
6. Clinical relevance of scrotal and transrectal ultrasonography in andrological patients
7. Contraceptive efficacy of testosterone-induced azoospermia in normal men
8. Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men
9. Suppression of human spermatogenesis by testosterone implants
10. Comparison of a gonadotropin-releasing hormone antagonist plus testosterone (T) vs. T alone as a potential male contraceptive regimen
11. Hormonal male contraception: Suppression of spermatogenesis with GnRH antagonists and testosterone
12. A combined regimen of cyproterone acetate and testosterone enanthate as a potentially highly effective male contraceptive
13. Transdermal testosterone adminstration in hypogonadal men: Comparison of pharmacokinetics at different sites of application and at the first and fifth days of application
14. Levonorgestrel
15. Physiological relationships between inhibin B, follicle stimulating hormone secretion and spermatogenesis in normal men and response to gonadotrophin suppression by exogenous testosterone
16. Clinical trial with testosterone undecanoate for male fertility control
17. An oral regimen of cyproterone acetate and testosterone undecanoate for spermatogenic suppression in men
18. Effects of gonadotropin and testosterone treatments on lipoprotein (a), high density lipoprotein particles, and other lipoprotein levels in male hypogonadism
19. Suppression of endogenous testosterone in young men increases serum levels of HDL-subclass LpA-I and lipoprotein(a)
20. Contraceptives containing desogestrel or levonorgestrel have different effects on serum lipoproteins and post-heparin plasma lipase activities
21. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism
22. Androgens, cardiovascular risk factors and atherosclerosis